1 in stock
HELIOST3 (an oral blend of T3, Yohimbine and Clenbuterol)
Combines the synergistic fat burning power of beta adrenergic agonists) and alpha adrenergic antagonists (Yohimbine HCl), all to add the T3 characteristics of increase the metabolic rate by increasing Thyroid efficiency.
Clenbuterol – 37.5mcg
T3 – 25mcg
Effects and Dosage
The blend is very potent combination of a beta and alpha antagonist. Clenbuterol and Yohimbine promote fat loss through the same adrenergic system, but the effects are achieved through different mechanisms. Clenbuterol is a known thermogenics shown to directly stimulate fat cells metabolism and accelerate the breakdown of triglycerides to form free fatty acids. The hormone glucagon released signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. Yohimbine, being an antagonist of alpha-2 receptors shifts the balance of sympathetic activity to ensure that lypolisis occurs. This increases synaptic Norepinephrine release, one of the body’s own natural Lipolytic hormones. In effect, it acts as beta stimulating and alpha blocking properties, an ideal combination to stimulate fat loss.
Administration and Use:
Clenbuterol should be built up and tapered off gradually with dosage increases and decreases every 3-4 days and doses never exceeding 160g per day for safety measures. It is administered for periods of 2-3 weeks then discontinued for equal periods of time to prevent the body’s metabolic system the ability to adapt to the metabolic effects. For fat-burning goals Clenbuterol is often stacked with another fat-burning agent for quick effect, or alternated with another fat-burning agent by people who need to stay lean for a promote period. Usually T 3 is used for such purposes, with alternating cycles of 3 weeks each. If used together, cycles will not completely overlap!!! And a new adjustment is needed. A typical cycle for Clenbuterol might be 3 weeks, with the daily amounts being:
Then stopping for three weeks and recommencing.
Patients should be instructed that the expected benefits of HELIOST3 may only be obtained when each tablet is swallowed with plain water the first thing upon arising for the day, at least 30 minutes before the first food, beverage, or medication of the day. Even ingestion with orange juice or coffee has been shown to markedly reduce the absorption of HELIOST3
To facilitate delivery to the stomach and thus reduce the potential should be instructed to swallow HELIOST3 with a full glass of tap water and not to lie down for at least 30 minutes and until after their first food of the day. Patients should not chew or suck on the tablet, or retain it in the mouth for a period longer than that required for swallowing, because a potential for side effects, not to take HELIOST3 at bedtime or before arising for the day.
Difficulty or pain upon swallowing, retrosternal pain or new or worsening heartburn), they should stop taking HELIOST3